Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0000950170-23-063918

Options or other derivatives

  • Director acquired 57,499 shares (grant or award)
  • Director acquired 13,269 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Moin Andrew Director 2023-11-10 Grant or award · Preferred Tranche A Warrants +13,269 13,269 I
Moin Andrew Director 2023-11-10 Grant or award · Preferred Tranche B Warrants +8,846 20,846 I
Moin Andrew Director 2023-11-10 Grant or award · Preferred Tranche C Warrants +22,115 52,115 I
Moin Andrew Director 2023-11-13 Option exercise · Preferred Tranche A Warrants −13,269 0 I
Moin Andrew Director 2023-11-13 Grant or award · Series A-1 Convertible Preferred Stock +13,269 $1,000.00 $13,269,000 13,269 I
Loading xslF345X05/ownership.xml…